Last $0.80 USD
Change Today 0.00 / 0.00%
Volume 0.0
PEYE On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 08/21/14 All times are local (Market data is delayed by at least 15 minutes).

precision optics corp inc (PEYE) Snapshot

Open
$0.80
Previous Close
$0.80
Day High
$0.80
Day Low
$0.80
52 Week High
10/22/13 - $1.09
52 Week Low
09/18/13 - $0.40
Market Cap
3.6M
Average Volume 10 Days
499.7
EPS TTM
$-0.10
Shares Outstanding
4.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PRECISION OPTICS CORP INC (PEYE)

Related News

No related news articles were found.

precision optics corp inc (PEYE) Related Businessweek News

No Related Businessweek News Found

precision optics corp inc (PEYE) Details

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells optical systems and components, optical thin-film coatings, and medical instruments to original equipment manufacturers in the United States. The company’s medical instrumentation products include endoscopes and endocouplers, Microprecision lenses, micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures. It also provides components and assemblies that are designed for industrial and military use. The company was founded in 1982 and is based in Gardner, Massachusetts.

27 Employees
Last Reported Date: 10/30/13
Founded in 1982

precision optics corp inc (PEYE) Top Compensated Officers

Chief Executive Officer, President, Treasurer...
Total Annual Compensation: $120.0K
Optical Shop Manager
Total Annual Compensation: $130.4K
Compensation as of Fiscal Year 2013.

precision optics corp inc (PEYE) Key Developments

Precision Optics Corporation, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014

Precision Optics Corporation, Inc. reported unaudited earnings results for the third quarter and nine months ended March 31, 2014. For the quarter, revenues were $833,451, as compared to $655,341 for the same period in the prior year, and represented an increase of 27.2%. Operating and net loss for the quarter ended March 31, 2014 was $380,434 or $0.09 per basic and diluted share, as compared to $349,994 or $0.08 per basic and diluted share for the same period in the prior year, and represented an increase of $30,440. Revenues for the nine months ended March 31, 2014 were $2,748,594, as compared to $1,717,406 for the same period in the prior year, and represented an increase of 60.0%. The increase in revenues for the quarter and nine months ended March 31, 2014 resulted from increases in the company's ongoing sales of previously developed products, as well as sales of newly designed products, most of which are used for medical applications. Operating loss for the nine months ended March 31, 2014 was $843,608, as compared to $1,060,313 for the same period in the prior year, and represented an improvement of $216,705. The decrease in the operating loss for the nine months ended March 31, 2014 as compared to the same period in the prior year is primarily attributed to lower research and development expenses incurred by the company, along with higher reported sales and gross profit, partially offset by higher selling, consulting, legal and stock-based compensation expenses incurred. Net loss for the nine months ended March 31, 2014 was $843,608 or $0.19 per basic and diluted share, as compared to a net loss of $1,614,572 or $0.50 per basic and diluted share for the nine months ended March 31, 2013.

Precision Optics Corporation, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2013

Precision Optics Corporation, Inc. reported unaudited earnings results for the second quarter and six months ended December 31, 2013. For the quarter, the company reported revenue of USD 1,007,717 against USD 498,667 a year ago. Operating loss was USD 252,453 against 353,475 a year ago. Net loss was USD 252,453 against USD 906,484 a year ago. Basic and diluted loss per share was USD 0.06 against USD 0.22 a year ago. The increase in revenues for the quarter resulted from increases in the company's ongoing sales of previously developed products, as well as sales of newly designed products, most of which are used for medical applications. The decrease in the operating loss for the quarter is primarily attributed to lower research and development expenses incurred by the company, along with higher reported sales and gross profit, partially offset by higher selling, consulting, legal and stock-based compensation expenses incurred. For the six months, the company reported revenue of USD 1,915,143 against USD 1,062,065 a year ago. Operating loss was USD 463,174 against 710,319 a year ago. Net loss was USD 463,174 against USD 1,264,578 a year ago. Basic and diluted loss per share was USD 0.10 against USD 0.47 a year ago. The increase in revenues for the six months ended December 31, 2013 resulted from increases in the company's ongoing sales of previously developed products, as well as sales of newly designed products, most of which are used for medical applications. The decrease in the operating loss for the six months is primarily attributed to lower research and development expenses incurred by the company, along with higher reported sales and gross profit, partially offset by higher selling, consulting, legal and stock-based compensation expenses incurred.

Precision Optics Corporation, Inc. Reports Unaudited Earnings Results for the First Quarter Ended September 30, 2013

Precision Optics Corporation, Inc. reported unaudited earnings results for the first quarter ended September 30, 2013. For the quarter, the company reported revenues were $907,426, representing an increase of 61.1% as compared to revenues of $563,398 for the same period in the prior year, and representing a quarter-over-quarter sequential increase of 13.1% as compared to revenues of $802,337 for the quarter ended June 30, 2013. The increase in revenues for the quarter ended September 30, 2013 resulted from increases in the company's ongoing sales of previously developed products, as well as sales of newly designed products, most of which are used for medical applications. Operating loss was $210,721, representing an improvement of $146,123, as compared to $356,844 for the same period in the prior year. The decrease in the operating loss in the quarter ended September 30, 2013 as compared to the same period in the prior year is primarily attributed to higher sales and gross profit and lower research and development expenses, partially offset by higher selling expenses. Net loss was $210,721, as compared to a net loss of $358,094 for the quarter ended September 30, 2012, representing an improvement of $147,373. The company used cash in operating activities of $147,033, an $89,152 improvement from the cash used in operating activities of $236,185 recorded for the quarter ended June 30, 2013. Basic and diluted loss per share was $0.05 against $0.27 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PEYE:US $0.80 USD 0.00

PEYE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PEYE.
View Industry Companies
 

Industry Analysis

PEYE

Industry Average

Valuation PEYE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.0x
Price/Book 3.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PRECISION OPTICS CORP INC, please visit www.poci.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.